» Authors » Deepa Gopalan

Deepa Gopalan

Explore the profile of Deepa Gopalan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 111
Citations 1949
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Baccelli A, Gopalan D, Davies R, Haji G, Gin-Sing W, Howard L, et al.
Life (Basel) . 2025 Jan; 15(1). PMID: 39859994
Background: Stroke volume index (SVI) is an important prognostic parameter in pulmonary arterial hypertension (PAH). The direct Fick (DF) method represents the gold standard for measuring it. Indirect Fick (IF)...
2.
Ashmore J, Prescott S, McLean J, Wilson D, Charles-Edwards G, Wright P, et al.
Br J Radiol . 2024 Nov; 98(1167):336-344. PMID: 39535863
UK guidelines for MR safety recommend that MRI departments refer to the implant manufacturer for advice regarding the MRI safety of scanning patients with an implantable medical device prior to...
3.
Rajagopal S, Bogaard H, Elbaz M, Freed B, Remy-Jardin M, van Beek E, et al.
Eur Respir J . 2024 Aug; 64(4). PMID: 39209480
Pulmonary hypertension (PH) remains a challenging condition to diagnose, classify and treat. Current approaches to the assessment of PH include echocardiography, ventilation/perfusion scintigraphy, cross-sectional imaging using computed tomography and magnetic...
4.
Corovic A, Zhao X, Huang Y, Newland S, Gopalan D, Harrison J, et al.
Cardiovasc Res . 2024 Jul; 120(14):1752-1767. PMID: 39073768
Aims: While acute cardiovascular complications of coronavirus disease 2019 (COVID-19) are well described, less is known about longer-term cardiac sequelae. For many individuals with cardiac signs or symptoms arising after...
5.
Wall C, Weir-McCall J, Tweed K, Hoole S, Gopalan D, Huang Y, et al.
Eur Heart J Cardiovasc Imaging . 2024 Mar; 25(7):1018-1027. PMID: 38493483
Aims: To assess pericoronary adipose tissue (PCAT) density on coronary computed tomography angiography (CCTA) as a marker of inflammatory disease activity in coronary allograft vasculopathy (CAV). Methods And Results: PCAT...
6.
Muscogiuri E, De Wever W, Gopalan D
Breathe (Sheff) . 2024 Mar; 20(1):230130. PMID: 38482190
Pulmonary embolism (PE) is a pathological entity characterised by venous thromboembolism in the pulmonary arteries. It is a common entity in daily clinical practice and is the third most common...
7.
Aggarwal V, Giri J, Visovatti S, Mahmud E, Matsubara H, Madani M, et al.
Circulation . 2024 Mar; 149(15):e1090-e1107. PMID: 38450477
Balloon pulmonary angioplasty continues to gain traction as a treatment option for patients with chronic thromboembolic pulmonary disease with and without pulmonary hypertension. Recent European Society of Cardiology guidelines on...
8.
van de Veerdonk M, Roosma L, Trip P, Gopalan D, Vonk Noordegraaf A, Dorfmuller P, et al.
Eur Respir Rev . 2024 Feb; 33(171). PMID: 38417969
Pulmonary hypertension (PH) is highly prevalent in patients with left heart disease (LHD) and negatively impacts prognosis. The most common causes of PH associated with LHD (PH-LHD) are left heart...
9.
Peverelli M, Maughan R, Gopalan D, Dweck M, Dey D, Buch M, et al.
Heart . 2024 Jan; 110(8):545-551. PMID: 38238078
Immune-mediated inflammatory diseases (IMIDs) are recognised risk factors for accelerated atherosclerotic cardiovascular disease (CVD), particularly in younger individuals and women who lack traditional CVD risk factors. Reflective of the critical...
10.
Lechartier B, Boucly A, Solinas S, Gopalan D, Dorfmuller P, Radonic T, et al.
Eur Respir Rev . 2024 Jan; 33(171). PMID: 38232988
Pulmonary veno-occlusive disease (PVOD), also known as "pulmonary arterial hypertension (PAH) with overt features of venous/capillary involvement", is a rare cause of PAH characterised by substantial small pulmonary vein and...